Neonatal intrahepatic cholestasis due to citrin deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

No FDA or trial events recorded yet for Neonatal intrahepatic cholestasis due to citrin deficiency.

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Neonatal intrahepatic cholestasis due to citrin deficiency.
Check the disease page for updates →

1 FDA-approved

IMPAVIDO

(miltefosine)Orphan drugstandard

Knight Therapeutics (USA)

Antileishmanial [EPC]

12.1 Mechanism of Action Miltefosine is an anti-leishmanial agent [see Clinical Pharmacology ( 12.4 )] .

No active clinical trials currently recruiting for Neonatal intrahepatic cholestasis due to citrin deficiency.
Search all trials →

No recent news articles indexed yet for Neonatal intrahepatic cholestasis due to citrin deficiency.
Search PubMed for Neonatal intrahepatic cholestasis due to citrin deficiency →

No specialists currently listed for Neonatal intrahepatic cholestasis due to citrin deficiency.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants